A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer

George Fountzilas; Urania Dafni; Meletios A Dimopoulos; Αngelos Koutras; Dimosthenis Skarlos; Pavlos Papakostas; Helen Gogas; Dimitrios Bafaloukos; Anna Kalogera‐Fountzila; Epaminontas Samantas; Evangelos Briasoulis; Dimitrios Pectasides; N Maniadakis; F. Matsiakou; Gerasimos Aravantinos; C. Papadimitriou; M. Karina; Christos Christodoulou; P. Kosmidis; Haralabos P. Kalofonos

doi:10.1007/s10549-008-0047-9

Related publications

Article2002

First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.

D. Pectasides, Meletios A Dimopoulos, Gerasimos Aravantinos, H. P. Kalophonos, P. Papacostas, Evangelos Briasoulis, E. Cogas, C Papadimitriou, D. Skarlos, P. Kosmidis, George Fountzilas

Article1998

Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.

George Fountzilas, A. Athanassiades, Vaios Papadimitriou, Meletios A Dimopoulos, D. Bafaloukos, Gerasimos Aravantinos, C. Nicolaides, Haralabos P. Kalofonos, Pavlos Papakostas, Nikolaos I. Xiros, Esma Razi

Article2025

SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma

Gregory M. Coté, Sant P. Chawla, George D. Demetri, Bernd Kasper, Robin L. Jones, Javier Martín‐Broto, Joseph Wooley, Mia C. Weiss, Salvatore Tafuto, Giuseppe Badalamenti, Irene Carrasco, Paloma Peinado, Jean Yves Blay, Gastón Boggio, Cristian Fernández, Antonio Nieto, Carmen Kahatt, Vicente Alfaro, Axel Le Cesne

Article2011

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer

George Fountzilas, D. Pectasides, Ioannis Efstratiou, Dimitra Repana, Evangelia Razis, Kostas Papazisis, Meletios A Dimopoulos, Christos N. Papandreou, C. Papadimitriou, Despina Televantou, Pavlos Papakostas, Gerasimos Aravantinos, George Pentheroudakis, Dimitrios Bafaloukos, Kalliopi Petraki, Constantina Christodoulou, Αngelos Koutras, Dimosthenis Miliaras, H. Kourea, Mattheos Bobos, Vasiliki Kotoula-Dimitriadou, Eleni Timotheadou

Article2024

Randomized controlled, open-label, phase IIb/III study of lurbinectedin in combination with doxorubicin versus doxorubicin alone as first-line treatment in patients with metastatic leiomyosarcoma.

Gregory M. Coté, Sant P. Chawla, George D. Demetri, Bernd Kasper, Robin L. Jones, Javier Martín‐Broto, Joseph Wooley, Mia C. Weiss, Salvatore Tafuto, Giuseppe Badalamenti, Irene Carrasco-García, Paloma Peinado, Jean Yves Blay, Gastón Boggio, Cristian Marcelo Fernandez, Antonio Martínez Nieto, Carmen Kahatt, Ali Zeaiter, Axel Le Cesne